跳至主要内容
临床试验/NCT02181452
NCT02181452已完成不适用

Evaluation of SWE Performances for the Non-Invasive Diagnosis of Liver Fibrosis in Patients With Chronic Liver Diseases

SuperSonic Imagine13 个研究点 分布在 9 个国家目标入组 2,333 人开始时间: 2013年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
2,333
试验地点
13
主要终点
Correlation coefficients between factors and liver stiffness

研究概览

简要总结

Chronic liver disease/fibrosis can be the result of various causes, and the result is that the liver tissue becomes stiff. ShearWave™ elastography, available on the Aixplorer® ultrasound system, is a method that can be used to measure the stiffness of organs in the body, for example the liver.

This study will evaluate how this technology performs as a non-invasive test to stage liver fibrosis in patients with chronic liver disease.

详细描述

The measurements of liver stiffness made by the Aixplorer® will be compared to (where available) :

  • blood markers
  • biopsy results
  • other stiffness measurement exams (FibroScan, ARFI, ElastPQ...)

The influence of other (confounding) factors on the reliability of SWE measurements will be analyzed.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients meeting a single condition below:
  • Chronic hepatitis B, defined by serology HBsAg positive and the presence of DNA / RNA in the serum, or
  • Chronic hepatitis C, defined by serology anti-HCV positive and the presence of DNA / RNA in the serum, or
  • non-alcoholic fatty-liver disease
  • And meeting all of the conditions below:
  • liver biopsy for histological evaluation of liver fibrosis
  • Length of liver biopsy ≥ 15 mm paraffin sections (except if cirrhosis)
  • Age of majority in their country
  • Obtaining the signature of consent for participation in the data collection, in addition to the routine consent form routinely used at the sites.

排除标准

  • Cause of chronic liver disease other than viral (alcohol, hemochromatosis, autoimmune hepatitis, biliary tract disease intrahepatic...) and other than non-alcoholic fatty-liver disease
  • History of antiviral therapy for 6 months or less of current antiviral therapy
  • Any systemic, viral hepatitis and HIV co-infection
  • Pregnant woman
  • Failure to obtain consent
  • Length of all liver biopsy specimens below 15mm

结局指标

主要结局

Correlation coefficients between factors and liver stiffness

时间窗: Within one year of the study start date

Factors include patient's clinical and biological parameters

次要结局

  • Sensitivity, specificity, positive and negative predictive values of the best multivariate model to assess liver fibrosis(Within one year of the study start date)
  • Diagnostic performance of multivariate models to assess liver fibrosis levels(Within one year of the study start date)
  • Technical success rates depending on factors(Within one year of the study start date)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (13)

Loading locations...

相似试验